Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Rheumatology (Oxford). 2017 May 1;56(5):855-856. doi: 10.1093/rheumatology/kew495.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / diagnostic imaging
  • Arthritis, Rheumatoid / drug therapy
  • Brain / diagnostic imaging*
  • Encephalitis, Tick-Borne / complications*
  • Encephalitis, Tick-Borne / diagnostic imaging
  • Fatal Outcome
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / diagnostic imaging
  • Lupus Erythematosus, Systemic / drug therapy
  • Magnetic Resonance Imaging
  • Rituximab / therapeutic use*

Substances

  • Antirheumatic Agents
  • Rituximab